CN
CN
About CD Capital

Run by a group of healthcare industry veterans, CD Capital backs great entrepreneurs and disruptive companies that prevent, detect, and cure diseases, with venture funds and industry resources. We are managing multiple USD and RMB funds, with an AUM over $1.3 Billion, and have provided venture funds for more than 80 companies to achieve their full potential. 

  • 2013

    Founded in 2013

  • 1.3 Billion

    Over 1.3 billion dollars

  • 80

    Over 80 portfolio investments

Learn More
Portfolio
KingMed
603882.SH. A pioneer and leader of the Independent Clinical Laboratories (ICL) industry.
Berry Genomics
000710.SZ. A leading company in clinical genomics and life science.
Righton
688217.SH. A leading company in tumor genetic diagnosis.
Creative Biosciences
An advanced bio-tech enterprise in fecal DNA testing.
Accunome
A high-tech enterprise focusing on infectious and critical diseases diagnosis.
Matridx
An innovative technology enterprise focused on the molecular diagnosis of infectious diseases.
Yingsheng
A pioneer in clinical mass spectrometry.
Reliable Med
An IVD company dedicated in original clinical mass spectrometry equipment and supporting kits.
ET Healthcare
Continuing innovations in diagnostics and life sciences
iRay Technology
A leader in the development and manufacturing of key X-ray system components.
Bioheart
A leading interventional cardiovascular device company.
Microtech Medical
A pioneer in the diabetes management medical devices industry.
BMC
A company provides integrated service to sleep-disordered breathing (SDB) and other chronic respiratory diseases.
Jenscare
A leading minimally invasive catheter valve research and development company.
Wallaby
A medical device company focused on medical device products for treating stroke.
Percutek Therapeutics
An innovative enterprise for cardiovascular minimally invasive devices.
Smartee
A leading brand in tooth invisible appliance.
Soonsolid
A company specialized in print system and material innovation.
Westlake
A cell therapy product research and develop company.
Huigene
A gene therapy drug research and develop company.
Westlake Omics
Engaged in the application of proteomics research to clinical diagnosis.
Kanova
An innovative immunotherapy antibody drug R&D company.
News
2023-09-06
Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million
---
2022-10-10
SprintRay Co. Secures Over $100 Million in Series D Funding, with Continued Support from CD Capital
---
2024-01-04
Global radiotherapeutics company Full-Life Technologies announces USD $47.3 million Series B financing, Prosperity7 Ventures jointly leads the round
---
Learn More
Contact
Room 3906, 1168 West Nanjing Road, Shanghai, China
Tel:+86 21 62609156
Learn More
About CD Team Portfolio News Contact
2021© CDBI Partners. All Rights Reserved. 沪ICP备2022023077号-1
沪公网安备 31010602006870号 上海甲辰投资有限公司
Follow Us